Pediatric Oral Thrush Treatment
For uncomplicated pediatric oral thrush, nystatin oral suspension (100,000-200,000 units four times daily for 7-14 days) is the first-line treatment, with fluconazole (3-6 mg/kg daily for 7-14 days) reserved as a superior alternative for treatment failures or more severe cases. 1, 2, 3
First-Line Treatment: Nystatin
Nystatin oral suspension remains the standard initial therapy for most cases of pediatric oral thrush. 1, 2, 3
Dosing by Age:
- Infants: 2 mL (200,000 units) four times daily, using a dropper to place half the dose in each side of the mouth 3
- Premature/low birth weight infants: 1 mL (100,000 units) four times daily is effective 3
- Children and older: 4-6 mL (400,000-600,000 units) four times daily 3
Administration Details:
- Apply after feedings and have the child retain the medication in the mouth as long as possible before swallowing 2, 3
- Continue treatment for at least 48 hours after symptoms resolve and cultures confirm eradication of Candida albicans 3
- Standard duration is 7-14 days, with shorter courses (1-7 days) acceptable in uncomplicated pediatric cases 1
Second-Line Treatment: Fluconazole
Fluconazole is significantly more effective than nystatin but is typically reserved for treatment failures, severe cases, or immunocompromised children. 4, 5
When to Use Fluconazole:
- Nystatin treatment failure or frequent recurrences 4
- Immunocompromised children 5
- Severe or extensive disease 1
- Patient/parent preference for once-daily dosing 4
Dosing:
- Standard dose: 3-6 mg/kg once daily for 7-14 days 1, 2, 6
- Loading dose option: 6 mg/kg on day 1, followed by 3 mg/kg daily 6
- Maximum daily dose: Should not exceed 12 mg/kg/day 6
Evidence for Superiority:
- Clinical cure rates: 91-100% with fluconazole vs. 32-51% with nystatin 4, 5
- Organism eradication: 76% with fluconazole vs. 11% with nystatin 5
- Relapse rates are similar between both agents (18-28% at 2-4 weeks post-treatment) 5
Alternative Agents
Miconazole oral gel (15 mg four times daily) is more effective than nystatin but raises concerns about generating triazole resistance. 1, 7
- Clinical cure by day 5: 84.7% with miconazole vs. 21.2% with nystatin 7
- Not routinely recommended as first-line due to resistance concerns 1
Special Populations
Neonates:
- Nystatin 100,000 units four times daily is preferred 3
- Fluconazole dosing in premature newborns (gestational age 26-29 weeks): administer every 72 hours for the first 2 weeks of life, then transition to once daily 6
Breastfeeding Dyads:
- Treat both mother and infant simultaneously to prevent reinfection 2
- Infant: Nystatin suspension 1 mL (100,000 units/mL) four times daily for 7-14 days 2
- Mother: Topical miconazole cream to nipples/areola after each feeding 2
- For persistent cases in mothers: oral fluconazole 100-200 mg daily for 14-30 days 2
Common Pitfalls and Prevention
Treatment failure is most commonly due to inadequate duration of therapy or reinfection from contaminated sources. 3, 5
- Continue treatment for at least 48 hours after clinical resolution 3
- Keep affected areas dry between feedings 2
- Sterilize pacifiers, bottle nipples, and toys that go in the mouth
- For breastfeeding mothers, treat maternal nipple candidiasis concurrently 2
Treatment-Resistant Cases
If thrush persists despite appropriate nystatin or fluconazole therapy, consider:
- Underlying immunodeficiency (requires investigation) 8
- Non-albicans Candida species (may require culture and susceptibility testing) 1
- Alternative azoles: itraconazole 200 mg/day or voriconazole for fluconazole-refractory disease 1
- Intravenous amphotericin B deoxycholate 0.3 mg/kg/day for severe refractory cases 1